Prostate Cancer 

Prostate cancer is the most common cancer in men in the UK, with over 40,000 new cases diagnosed every year. UCLH is the London Cancer Centre for the surgical treatment of prostate cancer and accepts referrals across the London Cancer Network, nationally and internationally.

We offer robotic surgery, focal and ablative surgery as well as radiotherapy and high dose rate brachytherapy. Our surgeons are experienced high volume urologists and our oncologists and specialist nurses work as a team with referring hospitals to ensure that patients receiving treatment at UCLH continue to have follow-up at their local hospital close to home.

UCLH is the largest centre for robotic prostate surgery in the UK and we use the da Vinci® robotic surgical system to remove the prostate gland. Robotic surgery is a form of keyhole surgery, the surgeon controls miniaturised instruments to undertake the procedure. We and others have found that patients benefit from the precision of robotic surgery through a reduced recovery time, reduced pain following the procedure and from far less visible scarring.

At UCLH we have introduced focal therapy alongside radiotherapy, robotic surgery and active surveillance to ensure that men with prostate cancer have options and choice. We are innovators in the field of prostate cancer diagnostics. In November 2015, the team won the ‘Acute Sector Innovation’ Health Service Journal award for innovation in diagnosing and treating prostate cancer. The team have addressed how to better diagnose prostate cancer by utilising methods that require fewer, but more accurate biopsies. Our dedicated radiologists are world leaders in the field of prostate imaging and, working together we have pioneered techniques to improve the precision of prostate cancer diagnostics.

We recognise that being diagnosed with cancer can be a difficult time for you and those close to you. These web pages give you an overview of the expert care you can expect to receive at UCLH. You will also be introduced to the different type of healthcare professionals you may meet along the way. As a team offering the range of therapeutic and surveillance options, our aim is to be able to offer an individually tailored treatment option to ensure cancer control and minimise side effects for men with prostate cancer.


Prof John Kelly, Consultant Urological Surgeon and Clinical Lead for Urology

Prof John Kelly

Professor John Kelly is a consultant urological surgeon specialising in robotic surgery for bladder and prostate cancer. He is the lead for the London Cancer Urology Surgery Centre and the robotic surgery programme at UCLH. John is the Professor of Uro-Oncology at UCL and his research group explore how new therapies for bladder and prostate cancer can improve outcomes for patients. He is Chief Investigator for multicentre clinical trials including studies which identify genomic alterations in cancer for the early detection of disease.

John Kelly is the Clinical Lead for Urology at University College Hospital Westmoreland Street. The department is one the largest in Europe and delivers cutting edge surgery using the latest technologies The position, working with teams across the many different aspects of Urology and leaders in the field is highly rewarding.

John moved to UCLH in 2009 from Cambridge University having worked at Addenbrookes in complex cancer surgery and as a fellow at the Cornell University Hospital, New York. He is known Internationally for his pioneering work in robotic surgery and is the Director of the Chitra Sethia Minimal Access Centre at UCH which trains robotic surgeons from the UK and abroad. John has been the Chairman of the UK National Cancer Research Institute, Bladder Clinical Studies Group and is currently the Chairman of the Scientific Committee of The Urology Foundation. John holds the Orchid Chair of Male Genito-Urinary Oncology with the Orchid Charity.

“I work with great people in urology and they have a common goal, we strive to provide the best care in a safe and caring environment providing high quality surgery”

Full consultant profile

Mr Prasanna Sooriakumaran

Mr Sooriakumaran @PSUrol qualified with a First Class degree in Human Anatomy and Cell Biology and a Medical Degree with Honours, before completing his Surgical and Urology Training in London. He obtained a PhD in Prostate Cancer and graduated from Robotic Prostatectomy and Cystectomy Fellowships at Cornell University, New York and the Karolinska Institute, Stockholm, before being appointed as an Academic Consultant Urologist at the University of Oxford, UK. At Oxford, he became the highest volume robotic surgeon performing half of all the robot-assisted radical prostatectomies. In January 2017, he moved to UCLH and continues to perform robot-assisted radical prostatectomy in large numbers.

Full consultant profile

Mr Manit Arya, Consultant Urological Surgeon

Mr Manit Arya

Mr Manit Arya qualified from Manchester Medical School. Following a basic surgical rotation around Manchester and Birmingham, he completed his higher specialist training in Urology in the North London rotation.

His clinical interests are in establishing the latest innovative techniques in the treatment of prostate cancer such as focal HIFU and cryotherapy. He leads the prostate cryotherapy programme at UCLH and is an international mentor for both HIFU and cryotherapy. UCLH is the largest volume focal prostate cryotherapy centre in Europe.

His research interests include investigating the metastatic process of prostate cancer at a molecular level. This research is continuing. He has published extensively throughout the Urology literature particularly in the field of urological oncology and has edited ten textbooks and published approximately 200 articles in peer-reviewed journals. He is a Principal Investigator on several National clinical trials involving focal therapies for prostate cancer.

“The focal therapy unit at UCLH is arguably the world’s leading prostate treatment unit. In relation to this tissue preserving approach, patients have access to the latest research and advances in the management of prostate cancer provided by world leading clinicians in this field.”

Full consultant profile

Mr Tim Briggs, Consultant Urological Surgeon

Mr Tim Briggs

Mr Briggs is a Consultant Urological Surgeon at UCLH and the Royal Free NHS Trust. He qualified from St Bartholomew's Medical School in 1984. After gaining his FRCS he embarked on a career in Urology at The Middlesex Hospital. Having completed his training, he then spent a year in the Concorde Hospital in Sydney, Australia.

As a Consultant he has developed an interest in prostate cancer and bladder cancer and developed the laparoscopic radical prostatectomy service at Barnet Hospital in 2004 and was one of the first surgeons performing this operation in the UK. From 2010 he has converted to the da Vinci Robotic System. In 2012 he joined the pelvic cancer team at UCLH where he routinely performs robotic radical prostatectomies for the treatment of prostate cancer and cystoprostatectomies (removal of prostate and bladder) for the treatment of bladder cancer. Formation of the ileal conduit or neobladder is also performed intracorporally.

Mr Briggs has performed over 200 Laparoscopic prostatectomies and 400 robotic radical prostatectomies.

“At UCLH we have developed the prostate planning meetings so that each patient’s procedure is planned individually from reviewing MRI and pathology. This has helped to increase the number of nerve sparing operations we perform and also alerts the surgeon to areas of possible capsular or extracapsular disease. We have also instigated and published the results of a Quality assurance program. As a teaching hospital we are also responsible for teaching the next generation of Robotic surgeons a role which I take very seriously.”

Full consultant profile

Dr Reena Davda, Consultant Oncologist

Dr Reena Davda

Dr Reena Davda is a Consultant in Clinical Oncology at UCLH. Dr Davda qualified from Edinburgh Medical School in 2002. She trained in Clinical Oncology in leading cancer centres across London including UCLH and the Royal Marsden. Reena has undertaken research at University College London investigating signalling pathways in prostate cancer stem like cells.

Dr Davda specialises in the management of prostate and bladder cancer and practices at both University College London Hospital and Princess Alexandra Hospital, Harlow. Alongside her clinical and academic practice, Reena is also involved in teaching, training and supervision of junior doctors and research fellows.

Full consultant profile

Prof Mark Emberton, Consultant Urological Surgeon

Prof Mark Emberton

Professor Mark Emberton and the prostate cancer team have transformed one of the most common cancer pathways. Imaging was introduced, as was the process of targeted prostate biopsy. Together these innovations have resulted in fewer biopsies, better biopsies and more precise risk-stratification. In addition, the minimally invasive treatments that he, and the team have introduced, has meant that many men can have their prostate cancer treated without any side-effects.

He has published over 300 scientific papers, lectures internationally and is a sought after visiting professor. He was awarded NHIR Senior Investigator status in 2015.

In August 2015 he was appointed as Dean of the Faculty of Medical Sciences at UCL.

Full consultant profile

Miss Tamsin Greenwell, Consultant Urological Surgeon

Miss Tamsin Greenwell

Miss Tamsin Greenwell has been a consultant urological surgeon specialising in female, functional and restorative (FFR) urology at UCLH since 2002. She leads the FFR Urology Unit and, along with her consultant colleagues Mr Jeremy Ockrim, Mr Rizwan Hamid and Mrs Mahreen Pakzad, provides male and female urinary incontinence treatment at UCLH.

Full consultant profile

Mr Anand Kelkar, Consultant Urological Surgeon

Anand Kelkar is Consultant Urological Surgeon working at the University College Hospital, London. He is one of our high volume surgeons with more than twenty years of experience in treating prostate and bladder cancer. The main focus of his practice is Robotic Prostatectomy and pelvic surgery.

Full consultant profile

Dr Mark Linch, Consultant Oncologist

Dr Mark Linch

Dr Mark Linch is a Consultant Medical Oncologist specialising in the treatment of prostate and bladder cancer, and Honorary Senior Lecturer at University College London (UCL) Cancer Institute where he leads the Uro-oncology Biology Group.

Dr Linch is currently Principal Investigator or Co-investigator in numerous clinical trials in prostate, bladder and penile cancer, both early and late phase, meaning that most patients at UCLH will have the opportunity to be involved in cutting edge therapeutic research. Dr Linch leads on a number of studies involving in depth profiling of patients’ cancers, looking for genetic, protein and immune cell changes that are associated with cancer. Through this work, Dr Linch hopes to be able to match individual patients with effective therapies, incorporate immunotherapy into routine clinical practice for urological malignancies and help develop novel therapies.

“Through an in depth understanding of my patients and the underlying biology of their cancer, I aim to give a personalised treatment and strive to be able to develop truly individualised anti-cancer therapies in the future. The skill and dedication of the uro-oncology team that I work with at UCLH, combined with the highest quality science at UCL, means that these aims can become a reality.”

Full consultant profile

Dr Ursula McGovern, Consultant Oncologist

Dr Ursula McGovern is a consultant medical oncologist, working at UCLH and the Royal Free NHS Trust. She was appointed a consultant in 2011, after completing her higher specialist oncology training in London and obtaining a PhD in molecular oncology from Imperial College, funded by Cancer Research UK. Her PhD research focused on the role of FOXO transcription factors in sensitivity to chemotherapy.

She specialises in the treatment of prostate and bladder cancer and is Principle or Co-Investigator on many national trials at both UCLH and Barnet Hospital for men with advanced prostate cancer and patients with bladder cancer, collaborating with a number of other centres in the UK and Internationally.

She has a keen interest in medical education, both postgraduate and undergraduate, and lectures for The Institute of Urology and is also the Undergraduate Lead for Oncology at UCL, responsible for overseeing the oncology teaching delivered to UCL medical students.

Full consultant profile

Dr Anita Mitra, Consultant Oncologist

Dr Anita Mitra

Dr Anita Mitra is a consultant in Clinical Oncology at University College London Hospitals. She has a busy practice managing prostate, bladder, andrology and gynaecological malignancies.

Dr Mitra qualified in London in 1995. She trained in Oncology in London teaching hospitals and the Royal Marsden, completing her research doctorate in prostate cancer from the Institute of Cancer Research. She has published widely and leads in the management of a portfolio of clinical trials.

Dr Mitra’s interest is in the innovation of technical radiotherapy. The aim of this research is to use novel techniques to minimise dose to normal tissues while maximising tumour control.

Full consultant profile

Ms Caroline Moore, Consultant Urological Surgeon and Senior Lecturer in Urology

Ms Caroline Moore

Caroline Moore was a Royal College of Surgeons research fellow in 2002, working on photodynamic therapy for prostate cancer. She has pursued a clinical academic career since then, developing a portfolio of trials in a number of aspects of prostate cancer diagnosis and management. She holds current funding awards from Prostate Cancer UK, Movember, the Cancer Vaccine Institute, the National Institute for Health Research, the European Association of Urology Research Foundation, the Wellcome Trust and the Department of Health.

Caroline is committed to individualised prostate cancer assessment and treatment, combining imaging with shared decision making for men with localised prostate cancer. She has particular interests in using patient reported outcomes to identify and disseminate best surgical practice; the use of MRI and different approaches to psychological support for men on active surveillance; decision making in localised prostate cancer; and the development of non-traditional follow up methods after prostate cancer diagnosis.

''Our prostate cancer team at UCLH is fortunate to be able to offer the highest quality prostate imaging, along with a novel approach to active surveillance and focal treatment, to give men the widest choice of options. We also seek to support men in their decision making, so that they have the best information to make the right decision for them''.

Full consultant profile

Mr Senthil Nathan, Consultant Urological Surgeon

Mr Senthil Nathan

Senthil Nathan is a Consultant Urological Surgeon and Honorary Clinical Senior Lecturer, working at UCLH and is Director of Robotic Education in Chitra Sethia Centre for Robotics and Minimally Invasive Surgery.

After graduating MBBS with honours from The Madras Medical College, Senthil completed his Masters in Surgery from Bangalore Medical College where he won The Association of Surgeons of India Gold Medal for securing the highest mark in the surgical exit exam. While working as an Assistant Surgeon in The Church of South India Hospital in Bangalore he was one among the first candidates to be selected by the Royal College of Surgeons of England to continue specialist training in the Overseas Training Scheme.

After working in general surgery and obtaining FRCS in Yorkshire he obtained a Diploma in Urology while working at Royal Free Hospital. He secured an Honorary Lecturer position at Guys Hospital to develop robotic techniques in urology. Along with Mr John Wickham and colleagues from The Imperial College he developed The Probot, and carried out the first true robotic surgery in the world.

Full consultant profile

Prof Heather Payne, Consultant Oncologist

Prof Heather Payne

Professor Payne was appointed as consultant in clinical oncology at UCLH in 1997. She trained in London as a clinical oncologist and during this time developed an interest in urological oncology. She has a busy practice specialising in the management of urological malignancies and works within the urological cancers multidisciplinary team. She is actively involved in clinical research in therapeutic areas and has pioneered a programme of high dose-rate brachytherapy for prostate cancer at the UCH site.

“It has been a great pleasure to work as part of the prostate cancer team at UCH for the last 18 years and to be involved with the new therapies and advances in radiotherapy that mean we can now offer our men with this disease renewed hope for the future”

Full consultant profile

Dr Douglas Pendse, Consultant Radiologist

Dr Doug Pendse is a Consultant Radiologist at UCLH, specialising in diagnostic and interventional uroradiology.

Having completed surgical training in Oxford, Doug was awarded MRCS in 2005 and moved to UCL to embark upon a career in imaging research. After doctoral-level research in prostate cancer (Focal Therapy and PDT) he was awarded NIHR Academic Clinical Fellowship in radiology in 2007. Combining clinical training in radiology with translational MRI research, Doug was awarded FRCR and subsequently appointed as a post-doctoral NIHR Clinical Lecturer at UCL in 2012.

As a consultant uroradiologist Doug’s maintains an active research interest as well as his work in diagnostic and interventional radiology. His research focus includes functional MRI in abdominal and urological disease and the translation of preclinical imaging techniques into clinical practice.

Full consultant profile

Mr Prabhakar Rajan, Consultant Urological Surgeon

Mr Prabhakar Rajan Consultant Urological Surgeon

Prabhakar Rajan is a member of the robotic surgery team, and has a specialist interest in the treatment of prostate cancer by robot-assisted radical prostatectomy. Mr Rajan studied physiology and medicine at Cambridge University, and completed junior surgical and senior urological residencies in Edinburgh and Glasgow, respectively. After Fellowship training in robotic surgery at the Karolinska University Hospital, Stockholm, Sweden, he was appointed as a Consultant in Urology with an interest in general urology and laparoscopy within NHS Greater Glasgow and Clyde, and moved to UCLH and Barts Health NHS Trusts in October 2015.

Mr Rajan is one of only a handful of academic surgeons in the UK to be awarded an RCSEng/CR-UK Clinician Scientist Fellowship in Surgery, which supports a laboratory-based research programme at Barts Cancer Institute, Queen Mary University of London. Work in his laboratory focusses on how key genetic changes in prostate cancer cells allow them to become resistant to various treatments and spread to other parts of the body.

“I am very fortunate to have a varied and exciting job. On one day, I see and operate on a patient with prostate cancer, and on the next, I am studying the biology of how cancer cells behave in my laboratory. The overall goal is that through a better understanding of the science behind cancer, I can find more treatments for patients and improve their chances of beating the disease.”

Full consultant profile

Mr David Ralph, Senior Urologist and Genital Reconstructive Surgeon

Mr David Ralph

David Ralph is a consultant urologist at UCLH since 1996. He qualified from St Bartholomew's Medical School and trained in urology at Leeds and The Institute of Urology in London. His practice is now entirely confined to andrology having finished a Masters degree on Peyronie's Disease. He is Past-President of the British Society for Sexual Medicine, the Andrology Section of the British Association of Urological Surgeons and The European Society for Sexual Medicine. He is also a trustee and vice president of the patient charity –The Sexual Advice Association.

He runs a large multidisciplinary erectile dysfunction service and is Director of the Erectile Dysfunction Clinical Trials Unit. He runs a European training fellowship for penile prosthesis implantation as well as research fellowships studying the molecular biology of erectile dysfunction, Peyronie’s Disease and priapism. He is heavily involved in postgraduate training, running live surgery courses and lecturing both at the European School Of Urology and the American Association of Urology. Having built up the andrology sub-specialty into a five-man team, the unit is now the biggest tertiary referral team within UCLH and has both a national and international reputation.

His clinical interests include all aspects of erectile dysfunction and sexual medicine, Peyronie’s Disease and priapism, male infertility and major genital reconstruction.

“We are the biggest unit in the UK receiving both local and tertiary referrals from all over the UK. We offer the up to date treatments for all sexual problems, particularly after cancer therapy, which may involve the insertion of a penile prosthesis. The team is multidisciplinary involving counsellors, radiological imaging and nurses to teach techniques of treatment. All patients can be helped no matter how serious the sexual problem is”.

Full consultant profile

Dr Navin Ramachandran, Consultant Radiologist

Dr. Ramachandran qualified from Guy’s & St. Thomas. Following a year lecturing at St. George’s Medical School (during with he attained a PGHCE), he trained in general radiology (FRCR), followed by fellowships in interventional and urological radiology. The latter steered him to the centre of excellence at UCLH where he undertook subspecialist training and was appointed as a substantive consultant.

He is currently regional lead for renal cancer radiology and a core member of the prostate, bladder, penile and testicular MDTs. He also helped to establish the radical prostatectomy surgical planning meeting which been shown to improve surgical outcomes.

He is a core member of the urological interventional radiology team, undertaking a wide range of procedures including nephrostomies, ureteric stenting, biopsy and PCNL.

His main research interests are in the novel use of imaging in urological disease and the use of medical informatics to support patient care. He is currently joint national lead for the NIHR Health Informatics Collaborative in prostate cancer. Current imaging projects include the development of 3D renal models for nephrectomy / ablation planning and the use of touch-free interfaces in surgery.

“UCLH is renowned as a world leader in urological imaging. I feel very privileged to be part of this team, and indeed of the outstanding and inclusive, urological surgery and oncology teams.”

Full consultant profile

Mr Greg Shaw, Consultant Urological Surgeon

Mr Greg Shaw

Mr Greg Shaw is a Consultant Urological Surgeon responsible for caring for patients with prostate cancer.

He is a surgeon with a strong academic interest in the molecular biology of urological cancer, robotic surgery, diagnostic precision and risk stratification. He is currently leading a project to develop the Neurosafe technique (pioneered in Germany) for UK patients, which is designed to promote nerve sparing without compromising oncological control at robotic radical prostatectomy. UCLH is the first London hospital where this technique has been used. This technique will be evaluated scientifically in a planned randomized controlled study, which Greg is leading on.

In 2014 Greg’s research paper, published in the British Journal of Cancer, investigating the accuracy of diagnostic tests in prostate cancer, made international news including the front page of the Telegraph, the Times, the Guardian and the Mail. In order to manage the impact of the research Greg conducted TV and radio interviews for ITN, Sky news and the BBC.

“Robotic surgery offers the gold standard of treatment for localised prostate cancer. UCLH is a national centre for robotic surgery where we strive to deliver world class care. We are pioneering new technologies to counter uncertainties in preoperative staging of prostate cancer by promoting quality of life for post-operative patients by nerve sparing where possible without jeopardising the oncological control of their cancer.”

Full consultant profile

 Clinical Nurse Specialists (CNS)

Hilary Baker, Lead Clinical Nurse Specialist for Urological Cancer

Hilary trained as a RGN at UCH in 1983, and went on to have varied surgical experience, mainly in urology as a ward sister, and also a nurse manager in both the NHS and the private sector. In 1995 she was appointed a urology CNS at Central Middlesex Hospital when there was an increasing demand for nurses in specialist areas with knowledge and skills to support urology patients. In 2001, with funding from the NHS Plan, she was employed as uro-oncology CNS and team leader at Buckinghamshire NHS Trust.

In September 2014, Hilary was appointed as lead CNS for uro-oncology. She has a BSc (Hons) in Cancer and Palliative Care and is registered as a Specialist Practitioner in Adult Nursing with the Nursing and Midwifery Council. She has recently completed her MSc in Cancer Studies at Oxford Brookes University.

Hilary’s responsibilities within the Trust and London Cancer are to provide managerial and professional nursing leadership across the uro-oncology service. She oversees planning and delivery of cancer services to help personalise the cancer pathway for individual patients and to meet the complex information and holistic needs of patients and their families.

‘I am dedicated to providing safe evidence-based cancer care, and to continually assess the patient experience to improve our service’.

Janet Forgenie, Clinical Nurse Specialist, Prostate, Bladder and Penile Cancer

Janet Forgenie

Janet trained at the Kent and Canterbury NHS Trust qualifying in 1994 obtaining her BSc (Hons) degree in general nursing. She initially worked on a busy surgical ward specialising in urology/trauma orthopaedic and vascular surgery. Janet then travelled to Australia in 1999 to work in a private hospital where she did her initial training in chemotherapy administration. On returning to the UK Janet continued to work within oncology gaining more experience in caring for patients undergoing treatment for urological cancers. Janet was then appointed as a urology diagnostic CNS in Reading in 2002 where she set up several nurse led services including uro-dynamics. In 2008 she joined the Uro-Oncology team in Reading as a CNS gaining more experience in caring for patients with a urological cancer. Janet joined UCLH in 2016 as a member of the Uro-Oncology CNS team. During the course of her career Janet has also obtained her Msc Certificate and her Non-medical prescribers enabling her to work more autonomously.

“I have experience in setting up nurse led clinics which have proven a great success in reducing the clinic load for consultants, while providing a great service for the patients.”

Hazel McBain, Research Nurse and Team Lead for Uro-Surgery Trials

Hazel McBain Research Nurse

I am a senior research nurse working with patients diagnosed with non-muscle invasive bladder cancer. I identify patients who may be eligible for clinical studies and then co-ordinate their treatment and investigations in line with the protocol. Follow up varies from short to long term giving me the opportunity to develop good relationships with patients and their relatives.

This is an autonomous role which requires strict organisation and pro-activity in pushing projects forward, liaising with many different groups and departments both inside the healthcare system (R&D, pharmacy, radiology) and outside (pharmaceutical, inspectors, trials units).

“I enjoy the patient contact that this role demands.”

Anna Mohammed, Clinical Nurse Specialist for Robotics

Anna Mohammed CNS

Anna is the newest member of the team, having joined in 2014 to this unique role. Anna’s experience stems from having been a theatre sister in urology and she is currently completing her Master’s degree in Surgical Care Practice (Urology).

“I am passionate about empowering patients through education and delivering a high standard of care to our patients.”

Tel: 0798 439 1126


 Web chat